Robert Koch Institute, Berlin, Germany.
Intervirology. 2011 Feb;54(2):78-86. doi: 10.1159/000318892. Epub 2010 Sep 10.
To develop improved vaccination strategies against feline leukemia virus (FeLV), rats were immunized with the transmembrane envelope protein p15E of FeLV alone or in combination with the commercial vaccine Leucogen® comprising the nonglycosylated FeLV surface envelope protein. Binding and neutralizing antibodies were induced in both groups and in the group immunized with Leucogen alone. Higher titers of antibodies neutralizing FeLV were induced by simultaneous immunization with Leucogen and p15E compared to the responses using Leucogen or p15E alone, suggesting that combination vaccines should be used in the future. Epitope mapping of p15E-specific antibodies induced by simultaneous immunization with Leucogen and p15E revealed the same pattern of response as obtained after immunization with p15E alone: one epitope was localized in the membrane-proximal external region (MPER) and the other in the fusion peptide-proximal region, and they are related to the epitopes detected after immunization with p15E of the porcine endogenous retrovirus and the koala retrovirus. The data indicate that these epitopes in the MPER are an effective target for neutralization and that antigens containing them may therefore prove to be a useful component of vaccines against retroviruses, including HIV-1.
为了开发针对猫白血病病毒(FeLV)的改良疫苗接种策略,用 FeLV 的跨膜包膜蛋白 p15E 单独或与包含非糖基化 FeLV 表面包膜蛋白的商业疫苗 Leucogen®联合对大鼠进行免疫。两组和单独用 Leucogen 免疫的组都诱导了结合抗体和中和抗体。与单独使用 Leucogen 或 p15E 相比,同时用 Leucogen 和 p15E 免疫诱导的中和 FeLV 的抗体滴度更高,这表明未来应使用联合疫苗。同时用 Leucogen 和 p15E 免疫诱导的 p15E 特异性抗体的表位作图显示与单独用 p15E 免疫获得的反应模式相同:一个表位定位于膜近侧外部区域(MPER),另一个定位于融合肽近端区域,它们与用猪内源性逆转录病毒和考拉逆转录病毒的 p15E 免疫后检测到的表位有关。这些数据表明,MPER 中的这些表位是中和的有效靶标,因此包含这些表位的抗原可能被证明是针对包括 HIV-1 在内的逆转录病毒疫苗的有用成分。